GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 4.44M |
Day Range | - - - |
52 Wk Range | 0.24 - 3.53 |
Market Cap | $18.19M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 11.42% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GlycoMimetics (NASDAQ:GLYC) through any online brokerage.
Other companies in GlycoMimetics’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Evaxion Biotech (NASDAQ:EVAX) and Nanoviricides (AMEX:NNVC).
There is no analysis for GlycoMimetics.
GlycoMimetics has a consensus price target of $8.00.
The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.2821 last updated July 19, 2024 at 5:25 PM EDT.
There are no upcoming dividends for GlycoMimetics.
GlycoMimetics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for GlycoMimetics.
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.